# Edwards Lifesciences Corp: Form 8-K, filed May 8, 2020

- Company: [Edwards Lifesciences Corp](/companies/ew.md) (CIK 1099800)
- Form: 8-K
- Filed: 2020-05-08
- Accepted by EDGAR: May 8, 2020, 16:26 ET
- Period: 2020-05-07
- Accession: 0001193125-20-137597
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1099800/000119312520137597/d923809d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1099800/000119312520137597/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1099800/000119312520137597/d923809d8k.htm

Filed May 8, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-137597. Last ingested by Listed: Nov 15, 2026, 03:19 ET. No prices; not investment advice.
